UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000030781 |
|---|---|
| Receipt number | R000035146 |
| Scientific Title | Interview to medical doctors on their attitude towards integrative medicine |
| Date of disclosure of the study information | 2018/01/12 |
| Last modified on | 2018/01/12 10:55:47 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Interview to medical doctors on their attitude towards integrative medicine
Acronym
Interview to doctors on IM
Scientific Title
Interview to medical doctors on their attitude towards integrative medicine
Scientific Title:Acronym
Interview to doctors on IM
Region
| Japan |
Condition
Condition
Not applicable
Classification by specialty
| Not applicable |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
To clarify the attitudes and their backgrounds of medical doctors towards integrative medicine.
Basic objectives2
Others
Basic objectives -Others
To clarify the factors determining positive, intermediate, and negative attitudes.
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
the attitudes and their backgrounds of medical doctors towards integrative medicine.
Key secondary outcomes
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 20 | years-old | <= |
Age-upper limit
| 65 | years-old | >= |
Gender
Male and Female
Key inclusion criteria
1) Medical doctors working for Kanazawa Medical University
2) Those whom written informed consent can be obtained from
3) 3 doctors younger than 40 years old, 3 doctors older than 39 years old
4) 3males and 3 females
5) 6 from different department/specialty
6) 2 positive, 2 intermediate, and 2 negative attitude towards integrative medicine
Key exclusion criteria
Those whom written informed consent cannot be obtained from
Target sample size
6
Research contact person
Name of lead principal investigator
| 1st name | |
| Middle name | |
| Last name | Yoshiharu Motoo |
Organization
Kanazawa Medical Unversity
Division name
Department of Medical Oncology
Zip code
Address
1-1 Daigaku, Uchinada, Ishikawa 920-0293
TEL
076-286-2211
motoo@kanazawa-med.ac.jp
Public contact
Name of contact person
| 1st name | |
| Middle name | |
| Last name | Kazuho Hisamura |
Organization
Kanazawa Medical Unversity
Division name
Department of Medical Oncology
Zip code
Address
1-1 Daigaku, Uchinada, Ishikawa 920-0293
TEL
076-286-2211
Homepage URL
hisamura@kanazawa-med.ac.jp
Sponsor or person
Institute
Kanazawa Medical Unversity
Institute
Department
Personal name
Funding Source
Organization
Japan Agency for Medical Research and Development
Organization
Division
Category of Funding Organization
Japanese Governmental office
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Address
Tel
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2018 | Year | 01 | Month | 12 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Preinitiation
Date of protocol fixation
| 2018 | Year | 01 | Month | 10 | Day |
Date of IRB
Anticipated trial start date
| 2018 | Year | 01 | Month | 25 | Day |
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Participants are asked questions according to prepared questionnaires.
Management information
Registered date
| 2018 | Year | 01 | Month | 12 | Day |
Last modified on
| 2018 | Year | 01 | Month | 12 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000035146
